<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v2.3 20070202//EN" "archivearticle.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article"><front><journal-meta><journal-id journal-id-type="nlm-ta">Mol Cancer</journal-id><journal-title>Molecular Cancer</journal-title><issn pub-type="epub">1476-4598</issn><publisher><publisher-name>BioMed Central</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">1476-4598-6-74</article-id><article-id pub-id-type="pmid">18028549</article-id><article-id pub-id-type="doi">10.1186/1476-4598-6-74</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research</subject></subj-group></article-categories><title-group><article-title>Alterations of GPI transamidase subunits in head and neck squamous carcinoma</article-title></title-group><contrib-group><contrib id="A1" contrib-type="author"><name><surname>Jiang</surname><given-names>Wei-Wen</given-names></name><xref ref-type="aff" rid="I1">1</xref><xref ref-type="aff" rid="I3">3</xref><email>wwjiang33@hotmail.com</email></contrib><contrib id="A2" contrib-type="author"><name><surname>Zahurak</surname><given-names>Marianna</given-names></name><xref ref-type="aff" rid="I2">2</xref><email>mzahur1@jhmi.edu</email></contrib><contrib id="A3" contrib-type="author"><name><surname>Zhou</surname><given-names>Zeng-Tong</given-names></name><xref ref-type="aff" rid="I3">3</xref><email>zhouzengtong@hotmail.com</email></contrib><contrib id="A4" contrib-type="author"><name><surname>Park</surname><given-names>Hannah Lui</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>hlui1@jhmi.edu</email></contrib><contrib id="A5" contrib-type="author"><name><surname>Guo</surname><given-names>Zhong-Min</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>zmguo2000@yahoo.com</email></contrib><contrib id="A6" contrib-type="author"><name><surname>Wu</surname><given-names>Guo-Jun</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>gwu10@jhmi.edu</email></contrib><contrib id="A7" contrib-type="author"><name><surname>Sidransky</surname><given-names>David</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>dsidrans@jhmi.edu</email></contrib><contrib id="A8" contrib-type="author"><name><surname>Trink</surname><given-names>Barry</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>btrink@jhmi.edu</email></contrib><contrib id="A9" corresp="yes" contrib-type="author"><name><surname>Califano</surname><given-names>Joseph A</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>jcalifa@jhmi.edu</email></contrib></contrib-group><aff id="I1"><label>1</label>Department of Otolaryngology- Head and Neck Surgery, Head and Neck Cancer Research Division, Johns Hopkins Medical Institutions, 601 N. Caroline Street, 6th Floor, Baltimore, MD 21287-0910, USA</aff><aff id="I2"><label>2</label>Department of Oncology Biostatistics, Johns Hopkins Medical Institutions, Suite 1103, 550 North Broadway, Baltimore, 21205-2013, USA</aff><aff id="I3"><label>3</label>Department of Oral Medicine, The Ninth People's Hospital, School of Stomatology, Shanghai Jiao Tong University, 639 Zhizaoju Road, Huangpu District, Shanghai, Postcode 200011, China</aff><pub-date pub-type="collection"><year>2007</year></pub-date><pub-date pub-type="epub"><day>21</day><month>11</month><year>2007</year></pub-date><volume>6</volume><fpage>74</fpage><lpage>74</lpage><ext-link ext-link-type="uri" xlink:href="http://www.molecular-cancer.com/content/6/1/74"/><history><date date-type="received"><day>31</day><month>7</month><year>2007</year></date><date date-type="accepted"><day>21</day><month>11</month><year>2007</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2007 Jiang et al; licensee BioMed Central Ltd.</copyright-statement><copyright-year>2007</copyright-year><copyright-holder>Jiang et al; licensee BioMed Central Ltd.</copyright-holder><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/2.0"><p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/2.0"/>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</p><!--<rdf xmlns="http://web.resource.org/cc/" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:dc="http://purl.org/dc/elements/1.1" xmlns:dcterms="http://purl.org/dc/terms"><Work xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" rdf:about=""><license rdf:resource="http://creativecommons.org/licenses/by/2.0"/><dc:type rdf:resource="http://purl.org/dc/dcmitype/Text"/><dc:author> Jiang Wei-Wen wwjiang33@hotmail.com </dc:author><dc:title> Alterations of GPI transamidase subunits in head and neck squamous carcinoma </dc:title><dc:date>2007</dc:date><dcterms:bibliographicCitation>Molecular Cancer 6(1): 74-. (2007)</dcterms:bibliographicCitation><dc:identifier type="sici">1476-4598(2007)6:1&#x0003c;74&#x0003e;</dc:identifier><dcterms:isPartOf>urn:ISSN:1476-4598</dcterms:isPartOf><License rdf:about="http://creativecommons.org/licenses/by/2.0"><permits rdf:resource="http://web.resource.org/cc/Reproduction" xmlns=""/><permits rdf:resource="http://web.resource.org/cc/Distribution" xmlns=""/><requires rdf:resource="http://web.resource.org/cc/Notice" xmlns=""/><requires rdf:resource="http://web.resource.org/cc/Attribution" xmlns=""/><permits rdf:resource="http://web.resource.org/cc/DerivativeWorks" xmlns=""/></License></Work></rdf>--></license></permissions><abstract><sec><title>Background</title><p>GPI anchor attachment is catalyzed by the GPI transamidase (GPIT) complex. <italic>GAA1, PIG-T </italic>and <italic>PIG-U </italic>are the three of five GPIT subunits. Previous studies demonstrated amplification and overexpression of GPIT subunits in bladder and breast cancer with oncogenic function. We performed an analysis of these subunits in head and neck squamous cell carcinoma (HNSCC).</p></sec><sec><title>Results</title><p>To evaluate <italic>GAA1, PIG-T </italic>and <italic>PIG-U </italic>in HNSCC, we used quantitative PCR (QPCR) and quantitative RT-PCR (QRT-PCR) to determine the copy number of those genes in primary tumors and the matching lymphocytes in 28 patients with HNSCC and quantified RNA expression of those genes in 16 primary HNSCC patients and 4 normal control tissue samples. <italic>GAA1 </italic>showed a significant increase in normalized mRNA expression, 2.11 (95% CI: 1.43, 2.79), in comparison to that of normal controls, 0.43 (95% CI: -0.76, 1.61), p = 0.014 (<italic>Mann-Whitney test</italic>). The mean genomic copy number of <italic>GAA1 </italic>was significantly increased in HNSCC, 0.59 (95% CI: 0.50, 0.79), in comparison to lymphocyte DNA, 0.35 (95% CI: 0.30, 0.50), p = 0.001 <italic>(paired t-test)</italic>.</p></sec><sec><title>Conclusion</title><p>An increased expression level and elevated copy number for <italic>GAA1 </italic>suggest a role for this GPI anchor subunit in HNSCC.</p></sec></abstract></article-meta></front><body><sec><title>Background</title><p>HNSCC has an annual incidence of over than 40,000 cases per year in United States and is characterized by local tumor aggressiveness, a high rate of early recurrences, and development of second primary carcinomas [<xref ref-type="bibr" rid="B1">1</xref>]. Despite modern therapeutic strategies, overall 5-year survival rate does have only modestly improved.</p><p>Glycosylphosphatidylinositol (GPI) anchoring is a membrane attachment mechanism for cell surface proteins widely used in eukaryotes. GPI anchor attachment is catalyzed by GPI transamidase (GPIT) complex, which is composed of at least five subunits: <italic>Phosphatidylinositol Glycan Class U (PIG-U), Glycosylphosphatidylinositol Anchor Attachment Protein 1 </italic>(<italic>GAA1</italic>), <italic>Phosphatidylinositol Glycan Class K (Gpi8), Phosphatidylinositol Glycan Class S (PIG-S), Phosphatidylinositol Glycan Class T (PIG-T) </italic>[<xref ref-type="bibr" rid="B2">2</xref>-<xref ref-type="bibr" rid="B11">11</xref>]. All of the subunits are required for GPIT to function [<xref ref-type="bibr" rid="B3">3</xref>,<xref ref-type="bibr" rid="B6">6</xref>-<xref ref-type="bibr" rid="B8">8</xref>]. <italic>Gpi8 </italic>is the likely enzymatic component of the GPIT complex and can be cross-linked to proproteins [<xref ref-type="bibr" rid="B5">5</xref>,<xref ref-type="bibr" rid="B8">8</xref>,<xref ref-type="bibr" rid="B12">12</xref>-<xref ref-type="bibr" rid="B14">14</xref>]. <italic>GAA1 </italic>is able to assemble into <italic>PIG-U</italic>-containing GPIT complexes that are capable of interacting with a proprotein substrate, and this subunit also is critical in GPI recognition by GPIT [<xref ref-type="bibr" rid="B15">15</xref>]. <italic>PIG-U </italic>contains a sequence motif found in yeast and mammalian fatty acid elongases. This motif has been suggested to play a role in recognizing long chain fatty acids in GPI [<xref ref-type="bibr" rid="B3">3</xref>], and <italic>PIG-T </italic>contains endoplasmic reticulum (ER) localization information.</p><p>In a previous study amplification of <italic>PIG-U </italic>was noted in the bladder cancer, and was found to contribute to an oncogenic phenotype [<xref ref-type="bibr" rid="B16">16</xref>]. A recent study showed <italic>PIG-T </italic>and <italic>GPAA1 </italic>were overexpressed in breast cancer cell lines and primary tumors and caused malignant transformation <italic>in vitro </italic>[<xref ref-type="bibr" rid="B17">17</xref>]. Genomic amplification and/or DNA copy number gain are common genetic alterations in cancer that lead to the overexpression of oncogenes [<xref ref-type="bibr" rid="B18">18</xref>-<xref ref-type="bibr" rid="B20">20</xref>]. <italic>PIG-U </italic>and <italic>PIG-T </italic>are located at chromosome 20q and <italic>GAA1 </italic>is located at chromosome 8q, a chromosomal arm with increased copy number in HNSCC [<xref ref-type="bibr" rid="B21">21</xref>,<xref ref-type="bibr" rid="B22">22</xref>]. To evaluate <italic>PIG-U, PIG-T and GAA1 </italic>as possible oncogene candidates in HNSCC, we employed real-time PCR and real-time RT-PCR to determine copy number and RNA expression of those genes in primary HNSCCs.</p></sec><sec><title>Results and discussion</title><sec><title>Analysis of mRNA expression of <italic>GAA1</italic>, <italic>PIG-T </italic>and <italic>PIG-U </italic>by QRT-PCR</title><p>Overexpression of <italic>PIG-U</italic>, one of the GPIT subunits, was reported previously in primary bladder cancer and cell lines [<xref ref-type="bibr" rid="B16">16</xref>]. By comparing the mRNA expression ratios of the oral mucosa of normal subjects and tumor tissues of HNSCC patients, we were able to assess <italic>GAA1, PIG-T </italic>and <italic>PIG-U </italic>expression alteration in a quantitative manner. In this study, 68.75%, 31.25% and 43.75% of HNSCC exhibited higher mRNA expression in comparison to normal controls for <italic>GAA1, PIG-T and PIG-U</italic>, respectively (Fig <xref ref-type="fig" rid="F1">1</xref>). In particular, <italic>GAA1 </italic>showed a significant increase in mRNA expression in HNSCC, 2.11 (95% CI: 1.43, 2.79), in comparison to that in normal controls, 0.43 (95% CI: -0.76, 1.61), p = 0.014 (<italic>Mann-Whitney test</italic>).</p><fig position="float" id="F1"><label>Figure 1</label><caption><p>mRNA Expression Ratio of <italic>GAA1</italic>, <italic>PIGT </italic>and <italic>PIGU vs &#x003b2;-Actin</italic>. The expression differential of <italic>GAA1</italic>, <italic>PIGT </italic>and <italic>PIGU </italic>between normal (health subjects mucosa) and HNSCC was measured by calculating relative fluorescence amplification of transcripts of gene of interests normalized by the corresponding <italic>&#x003b2;-Actin </italic>signal. N, normal; T, HNSCC.</p></caption><graphic xlink:href="1476-4598-6-74-1"/></fig></sec><sec><title>Analysis of copy number of <italic>GAA1</italic>, <italic>PIG-T </italic>and <italic>PIG-U </italic>by QPCR</title><p>The combination of QPCR and QRT-PCR is a facile approach to detecting gene amplification and over-expression in tumor specimens. To assess whether the copy number of <italic>GAA1, PIG-T </italic>and <italic>PIG-U </italic>was altered in HNSCC, we performed QPCR in 28 HNSCC and matched peripheral leukocyte DNA. The relative copy number of each gene <italic>vs &#x003b2;-Actin </italic>is shown in Table <xref ref-type="table" rid="T1">1</xref>. Overall, a trend of increasing copy number was found in HNSCC. <italic>GAA1 </italic>copy number was significantly increased in primary HNSCCs, 0.59 (95% CI: 0.50, 0.79), in comparison to peripheral leukocyte DNA, 0.35 (95% CI: 0.30, 0.50), p = 0.001, while <italic>PIG-U </italic>showed a border line difference (<italic>paired t-test</italic>). (Fig <xref ref-type="fig" rid="F2">2</xref>) Taken together, the increased mRNA expression of <italic>GAA1 </italic>and low level copy number increase in HNSCC may be relevant as a possible contributor to oncogenic transformation in HNSCC.</p><table-wrap position="float" id="T1"><label>Table 1</label><caption><p>Copy number alteration of <italic>GAA1, PIG-T </italic>and <italic>PIG-U </italic>in HNSCC</p></caption><table frame="hsides" rules="groups"><thead><tr><td align="left">DNA Copy Number Ratio</td><td></td><td align="center">Number</td><td align="center">Mean</td><td align="center">Median</td><td align="center">95%CI</td><td align="center"><italic>p (paired-t test)</italic></td></tr></thead><tbody><tr><td align="left">Log <italic>(GAA1/&#x003b2;-Actin)</italic></td><td align="center">Control</td><td align="center">28</td><td align="center">0.40</td><td align="center">0.35</td><td align="center">(0.30, 0.50)</td><td align="center">0.001</td></tr><tr><td></td><td align="center">HNSCC</td><td align="center">28</td><td align="center">0.63</td><td align="center">0.59</td><td align="center">(0.50, 0.76)</td><td></td></tr><tr><td align="left">Log <italic>(PIG-T/&#x003b2;-Actin)</italic></td><td align="center">Control</td><td align="center">28</td><td align="center">0.34</td><td align="center">0.28</td><td align="center">(0.24, 0.45)</td><td align="center">0.365</td></tr><tr><td></td><td align="center">HNSCC</td><td align="center">28</td><td align="center">0.40</td><td align="center">0.43</td><td align="center">(0.30, 0.50)</td><td></td></tr><tr><td align="left">Log <italic>(PIG-U/&#x003b2;-Actin)</italic></td><td align="center">Control</td><td align="center">28</td><td align="center">0.59</td><td align="center">0.45</td><td align="center">(0.46, 0.72)</td><td align="center">0.058</td></tr><tr><td></td><td align="center">HNSCC</td><td align="center">28</td><td align="center">0.74</td><td align="center">0.64</td><td align="center">(0.61, 0.87)</td><td></td></tr></tbody></table></table-wrap><fig position="float" id="F2"><label>Figure 2</label><caption><p>Relative DNA copy number of <italic>GAA1</italic>, <italic>PIGT </italic>and <italic>PIGU </italic>in HNSCC. The copy number differential of <italic>GAA1, PIGT </italic>and <italic>PIGU </italic>between paired lymphocytes and HNSCC was measured by calculating relative fluorescence amplification of gene of interest normalized by the corresponding <italic>&#x003b2;-Actin </italic>signal using standard curve method. N, normal; T, HNSCC.</p></caption><graphic xlink:href="1476-4598-6-74-2"/></fig><p>Many membranous enzymes, receptors, differentiation antigens and other biologically active proteins proved to be bound to the plasma membrane by GPI. Recent studies report that there are increased levels of the GPI-anchored adhesion molecules <italic>CEACAM5</italic>, <italic>CEACAM6 </italic>and mesothelin in response to forced expression of <italic>&#x00394;N-TCF-1B</italic>, which could contribute to the induction of effecter molecules potentially relevant for tumor invasion in colorectal carcinomas patients [<xref ref-type="bibr" rid="B23">23</xref>]. Notably, our data showed that <italic>GAA1 </italic>copy numbers were much higher in HNSCC than in control white blood cells. This difference was highly significant, which was corresponded to the elevated RNA expression level in HNSCC patients.</p></sec><sec><title>Clinical associations with copy number alterations in <italic>GAA1</italic>, <italic>PIG-T </italic>and <italic>PIG-U</italic></title><p>To analyze whether clinical factors are associated with <italic>GAA1, PIG-T </italic>and <italic>PIG-U </italic>as potential markers, therefore, we further sub-grouped HNSCC patients by gender, race, stage and tumor site. We found that female HNSCC patients had a higher copy number of <italic>GAA1</italic>, 0.77 (95% CI: 0.63, 0.91), in comparison to male patients 0.58 (95% CI: 0.40, 0.75), p = 0.025 (<italic>Mann-Whitney test</italic>) (Table <xref ref-type="table" rid="T2">2</xref>). In comparison to <italic>GAA1</italic>, <italic>PIG-T </italic>showed significant difference of copy number in paired lymphocytes DNA between male and female patients but not in tumor tissue DNA (Table <xref ref-type="table" rid="T3">3b</xref>). Neither race nor tumor site was independently associated with <italic>GAA1 </italic>(Table <xref ref-type="table" rid="T2">2</xref>), <italic>PIG-T </italic>(Table <xref ref-type="table" rid="T3">3</xref>) and <italic>PIG-U </italic>(Table <xref ref-type="table" rid="T4">4</xref>) copy number alterations. One might, therefore, speculate that gender might be a factor in the catalysis of GPI anchor attachment. Five out of 28 HNSCCs were located in larynx. We noticed that the <italic>PIG-T </italic>DNA copy number of laryngeal HNSCC, showed a relatively lower value in comparison to that in the other sites (Table <xref ref-type="table" rid="T3">3</xref>), however, we were unable to draw definite conclusions due to limited case numbers. Additionally, no significances were shown among different stages for each gene.</p><table-wrap position="float" id="T2"><label>Table 2</label><caption><p>The effects of clinical parameters on copy number of <italic>GAA1</italic></p></caption><table frame="hsides" rules="groups"><thead><tr><td align="center">Log <italic>(Gaa1/&#x003b2;-Actin)</italic></td><td></td><td align="center">Number</td><td align="center">Mean</td><td align="center">Median</td><td align="center">95%CI</td><td align="center"><italic>p (Mann-Whitney test)</italic></td></tr></thead><tbody><tr><td align="center">Control</td><td align="center">Male</td><td align="center">20</td><td align="center">0.36</td><td align="center">0.33</td><td align="center">(0.25, 0.48)</td><td align="center">0.242</td></tr><tr><td></td><td align="center">Female</td><td align="center">8</td><td align="center">0.49</td><td align="center">0.39</td><td align="center">(0.29, 0.70)</td><td></td></tr><tr><td align="center">HNSCC</td><td align="center">Male</td><td align="center">20</td><td align="center">0.58</td><td align="center">0.44</td><td align="center">(0.40, 0.75)</td><td align="center">0.025*</td></tr><tr><td></td><td align="center">Female</td><td align="center">8</td><td align="center">0.77</td><td align="center">0.75</td><td align="center">(0.63, 0.91)</td><td></td></tr><tr><td align="center">Control</td><td align="center">White</td><td align="center">17</td><td align="center">0.35</td><td align="center">0.32</td><td align="center">(0.23, 0.46)</td><td align="center">0.165</td></tr><tr><td></td><td align="center">Other</td><td align="center">11</td><td align="center">0.48</td><td align="center">0.43</td><td align="center">(0.29, 0.68)</td><td></td></tr><tr><td align="center">HNSCC</td><td align="center">White</td><td align="center">17</td><td align="center">0.52</td><td align="center">0.48</td><td align="center">(0.42, 0.63)</td><td align="center">0.095</td></tr><tr><td></td><td align="center">Other</td><td align="center">11</td><td align="center">0.81</td><td align="center">0.68</td><td align="center">(0.52, 1.09)</td><td></td></tr><tr><td align="center">Control</td><td align="center">OC</td><td align="center">11</td><td align="center">0.35</td><td align="center">0.33</td><td align="center">(0.18, 0.53)</td><td></td></tr><tr><td></td><td align="center">HP</td><td align="center">3</td><td align="center">0.46</td><td align="center">0.43</td><td align="center">(0.05, 0.88)</td><td align="center">0.392</td></tr><tr><td></td><td align="center">L</td><td align="center">5</td><td align="center">0.42</td><td align="center">0.28</td><td align="center">(0.04, 0.80)</td><td align="center">0.865</td></tr><tr><td></td><td align="center">OP</td><td align="center">9</td><td align="center">0.43</td><td align="center">0.38</td><td align="center">(0.22, 0.64)</td><td align="center">0.518</td></tr><tr><td align="center">HNSCC</td><td align="center">OC</td><td align="center">11</td><td align="center">0.67</td><td align="center">0.68</td><td align="center">(0.39, 0.94)</td><td></td></tr><tr><td></td><td align="center">HP</td><td align="center">3</td><td align="center">0.55</td><td align="center">0.11</td><td align="center">(-0.26, 1.37)</td><td align="center">0.697</td></tr><tr><td></td><td align="center">L</td><td align="center">5</td><td align="center">0.65</td><td align="center">0.61</td><td align="center">(0.37, 0.92)</td><td align="center">0.955</td></tr><tr><td></td><td align="center">OP</td><td align="center">9</td><td align="center">0.61</td><td align="center">0.57</td><td align="center">(0.36, 0.86)</td><td align="center">0.676</td></tr></tbody></table></table-wrap><table-wrap position="float" id="T3"><label>Table 3</label><caption><p>The effects of clinical parameters on copy number of <italic>PIG-T</italic></p></caption><table frame="hsides" rules="groups"><thead><tr><td align="center">Log <italic>(PIG-T/&#x003b2;-Actin)</italic></td><td></td><td align="center">Number</td><td align="center">Mean</td><td align="center">Median</td><td align="center">95%CI</td><td align="center"><italic>p (Mann-Whitney test)</italic></td></tr></thead><tbody><tr><td align="center">Control</td><td align="center">Male</td><td align="center">20</td><td align="center">0.28</td><td align="center">0.25</td><td align="center">(0.15, 0.41)</td><td align="center">0.042*</td></tr><tr><td></td><td align="center">Female</td><td align="center">8</td><td align="center">0.51</td><td align="center">0.56</td><td align="center">(0.30, 0.72)</td><td></td></tr><tr><td align="center">HNSCC</td><td align="center">Male</td><td align="center">20</td><td align="center">0.37</td><td align="center">0.39</td><td align="center">(0.24, 0.49)</td><td align="center">0.222</td></tr><tr><td></td><td align="center">Female</td><td align="center">8</td><td align="center">0.48</td><td align="center">0.54</td><td align="center">(0.25, 0.71)</td><td></td></tr><tr><td align="center">Control</td><td align="center">White</td><td align="center">17</td><td align="center">0.33</td><td align="center">0.44</td><td align="center">(0.18, 0.47)</td><td align="center">0.621</td></tr><tr><td></td><td align="center">Other</td><td align="center">11</td><td align="center">0.37</td><td align="center">0.26</td><td align="center">(0.18, 0.57)</td><td></td></tr><tr><td align="center">HNSCC</td><td align="center">White</td><td align="center">17</td><td align="center">0.40</td><td align="center">0.45</td><td align="center">(0.29, 0.51)</td><td align="center">0.621</td></tr><tr><td></td><td align="center">Other</td><td align="center">11</td><td align="center">0.40</td><td align="center">0.41</td><td align="center">(0.16, 0.63)</td><td></td></tr><tr><td align="center">Control</td><td align="center">OC</td><td align="center">11</td><td align="center">0.39</td><td align="center">0.43</td><td align="center">(0.18, 0.61)</td><td></td></tr><tr><td></td><td align="center">HP</td><td align="center">3</td><td align="center">0.46</td><td align="center">0.54</td><td align="center">(-0.40, 1.33)</td><td align="center">0.938</td></tr><tr><td></td><td align="center">L</td><td align="center">5</td><td align="center">0.35</td><td align="center">0.25</td><td align="center">(-0.01, 0.72)</td><td align="center">0.692</td></tr><tr><td></td><td align="center">OP</td><td align="center">9</td><td align="center">0.24</td><td align="center">0.24</td><td align="center">(0.08, 0.40)</td><td align="center">0.239</td></tr><tr><td align="center">HNSCC</td><td align="center">OC</td><td align="center">11</td><td align="center">0.52</td><td align="center">0.52</td><td align="center">(0.34, 0.70)</td><td></td></tr><tr><td></td><td align="center">HP</td><td align="center">3</td><td align="center">0.44</td><td align="center">0.10</td><td align="center">(-0.34, 1.22)</td><td align="center">0.586</td></tr><tr><td></td><td align="center">L</td><td align="center">5</td><td align="center">0.20</td><td align="center">0.19</td><td align="center">(-0.08, 0.48)</td><td align="center">0.027*</td></tr><tr><td></td><td align="center">OP</td><td align="center">9</td><td align="center">0.35</td><td align="center">0.41</td><td align="center">(0.17, 0.53)</td><td align="center">0.271</td></tr></tbody></table></table-wrap><table-wrap position="float" id="T4"><label>Table 4</label><caption><p>The effects of clinical parameters on copy number of <italic>PIG-U</italic></p></caption><table frame="hsides" rules="groups"><thead><tr><td align="center">Log <italic>(PIG-U/&#x003b2;-Actin)</italic></td><td></td><td align="center">Number</td><td align="center">Mean</td><td align="center">Median</td><td align="center">95%CI</td><td align="center"><italic>p (Mann-Whitney test)</italic></td></tr></thead><tbody><tr><td align="center">Control</td><td align="center">Male</td><td align="center">20</td><td align="center">0.56</td><td align="center">0.43</td><td align="center">(0.39, 0.72)</td><td align="center">0.476</td></tr><tr><td></td><td align="center">Female</td><td align="center">8</td><td align="center">0.66</td><td align="center">0.68</td><td align="center">(0.41, 0.92)</td><td></td></tr><tr><td align="center">HNSCC</td><td align="center">Male</td><td align="center">20</td><td align="center">0.65</td><td align="center">0.62</td><td align="center">(0.51, 0.80)</td><td align="center">0.053</td></tr><tr><td></td><td align="center">Female</td><td align="center">8</td><td align="center">0.95</td><td align="center">0.97</td><td align="center">(0.66, 1.24)</td><td></td></tr><tr><td align="center">Control</td><td align="center">White</td><td align="center">17</td><td align="center">0.56</td><td align="center">0.43</td><td align="center">(0.40, 0.71)</td><td align="center">0.655</td></tr><tr><td></td><td align="center">Other</td><td align="center">11</td><td align="center">0.64</td><td align="center">0.59</td><td align="center">(0.38, 0.89)</td><td></td></tr><tr><td align="center">HNSCC</td><td align="center">White</td><td align="center">17</td><td align="center">0.69</td><td align="center">0.68</td><td align="center">(0.53, 0.86)</td><td align="center">0.466</td></tr><tr><td></td><td align="center">Other</td><td align="center">11</td><td align="center">0.81</td><td align="center">0.64</td><td align="center">(0.56, 1.06)</td><td></td></tr><tr><td align="center">Control</td><td align="center">OC</td><td align="center">11</td><td align="center">0.57</td><td align="center">0.41</td><td align="center">(0.29, 0.86)</td><td></td></tr><tr><td></td><td align="center">HP</td><td align="center">3</td><td align="center">0.57</td><td align="center">0.43</td><td align="center">(-0.05, 1.19)</td><td align="center">0.484</td></tr><tr><td></td><td align="center">L</td><td align="center">5</td><td align="center">0.62</td><td align="center">0.59</td><td align="center">(0.27, 0.96)</td><td align="center">0.533</td></tr><tr><td></td><td align="center">OP</td><td align="center">9</td><td align="center">0.59</td><td align="center">0.43</td><td align="center">(0.36, 0.82)</td><td align="center">0.470</td></tr><tr><td align="center">HNSCC</td><td align="center">OC</td><td align="center">11</td><td align="center">0.83</td><td align="center">0.80</td><td align="center">(0.57, 0.10)</td><td></td></tr><tr><td></td><td align="center">HP</td><td align="center">3</td><td align="center">0.68</td><td align="center">0.54</td><td align="center">(-0.45, 1.81)</td><td align="center">0.586</td></tr><tr><td></td><td align="center">L</td><td align="center">5</td><td align="center">0.67</td><td align="center">0.57</td><td align="center">(0.19, 1.16)</td><td align="center">0.396</td></tr><tr><td></td><td align="center">OP</td><td align="center">9</td><td align="center">0.69</td><td align="center">0.64</td><td align="center">(0.51, 0.86)</td><td align="center">0.425</td></tr></tbody></table></table-wrap></sec></sec><sec><title>Conclusion</title><p>Our data indicate that increasing of copy number and mRNA expression of <italic>GAA1 </italic>is characteristic for HNSCC and <italic>GAA1 </italic>play a role for this GPI anchor subunit in HNSCC.</p></sec><sec sec-type="methods"><title>Methods</title><sec><title>Subjects</title><p>Genomic DNA samples from 28 HNSCC tissues and matching lymphocytes were subjected to QPCR analysis. RNA of tissue samples from 16 microdissected HNSCCs and 4 oral mucosal biopsies of healthy people were subjected to QRT-PCR. All samples were collected at the Department of Otolaryngology-Head and Neck Surgery, School of Medicine, The Johns Hopkins University, after appropriate approval was obtained from the Johns Hopkins institutional review board (IRB approval # <bold>03-04-11-131d</bold>).</p></sec><sec><title>Cell lines and culture conditions</title><p>DNA and RNA from a virally transformed human cutaneous keratinocyte cell line (HaCaT) were used as standards for QPCR and QRT-PCR. The HaCaT cell line was grown in DMEM media supplemented with 10% FBS and 1% Penicillin-Streptomycin. Media components were obtained from Gibco Invitrogen Corporation (Carlsbad, CA) and cells were incubated at 37&#x000b0;C in an atmosphere of 5% CO<sub>2</sub>/95% relative humidity.</p></sec><sec><title>Quantitative PCR</title><p>A Perkin-Elmer/ABI 7900 thermocycler (Applied Biosystems, CA) was used to perform QPCR amplification for <italic>&#x003b2;-actin</italic>, <italic>PIG-U, PIG-T </italic>and <italic>Gaa1</italic>. <italic>&#x003b2;-actin </italic>primer and probe sequences used previously were employed in this study [<xref ref-type="bibr" rid="B24">24</xref>]. <italic>PIG-U</italic>[<xref ref-type="bibr" rid="B16">16</xref>], <italic>PIG-T </italic>and <italic>GAA1 </italic>primer and probe sequences were listed in Table <xref ref-type="table" rid="T5">5</xref>. Primers were custom made and obtained from Invitrogen (Carlsbad, CA). All TaqMan probes (Applied Biosystems, Foster City, CA) were 5'-FAM and 3'-TAMRA labeled. PCR amplifications were carried out in buffer containing: 16.6 mM ammonium sulfate, 67 mM Trizma (pH 8.8), 2.5 mM MgCl<sub>2</sub>, 10 mM &#x003b2;-mercaptoethanol, 0.1% DMSO, 600 nM each of forward and reverse primers, 200 nM TaqMan probe, 0.6 units Platinum Taq polymerase, and 2% ROX reference dye. 500 picograms of DNA were used to amplify the mitochondrial regions whereas 10 ng were used to amplify <italic>&#x003b2;-actin</italic>. The real-time PCR reactions were performed in triplicate for each gene. Data analysis was performed using Microsoft Excel software.<italic>PIG-U, PIG-T </italic>and <italic>GAA1 </italic>were normalized using the corresponding <italic>&#x003b2;-actin </italic>signal.</p><table-wrap position="float" id="T5"><label>Table 5</label><caption><p><italic>PIG-U, PIG-T </italic>and <italic>GAA1 </italic>primer and probe sequences</p></caption><table frame="hsides" rules="groups"><thead><tr><td align="left">Gene</td><td align="left">Forward Primer</td><td align="left">Probe</td><td align="left">Reverse Primer</td></tr></thead><tbody><tr><td align="left"><italic>PIG-U</italic></td><td align="left">AGCCCTCCAGCCAGAGTTA</td><td align="left">CAGGCGAGTGCTTGGGCAGAAGA</td><td align="left">ACTTGTGACCCTGGACTCGAA</td></tr><tr><td align="left"><italic>PIG-T</italic></td><td align="left">GATCTGCCTCACGTGCACTGT</td><td align="left">TGGCCGTGTGCTATGGCTCCTTC</td><td align="left">AGGTTCGGGTGAGGAGATTGT</td></tr><tr><td align="left"><italic>Gaa1</italic></td><td align="left">CCGGGCTGGGACAGAGA</td><td align="left">TCCCCAAGGACCCCATTCTGCC</td><td align="left">CAGACACTCATTTATTTCCCCA</td></tr></tbody></table></table-wrap></sec><sec><title>Statistical analysis</title><p>The major statistical first endpoint in this study was the comparison of the difference in <italic>PIG-U, PIG-T </italic>and <italic>GAA1 </italic>quantitative DNA ratio between lymphocytes DNA and tumor tissue DNA in the HNSCC patients. The second endpoint in this study was <italic>PIG-U, PIG-T </italic>and <italic>GAA1 </italic>RNA expression differences between HNSCC patients and normal control subjects. Distributions of <italic>PIG-U, PIG-T </italic>and <italic>GAA1 </italic>DNA and RNA quantitative ratios were examined graphically using scatter plots and bar plots with logarithmic scales. Log transformation was chosen for these values and the difference taken for statistical analyses. Paired <italic>t-tests </italic>were used to determine if these changes were significantly different from each other. All statistical computations were performed using the SPSS system (SPSS, Chicago) and all p values reported are two-sided.</p></sec></sec><sec><title>Authors' contributions</title><p>WWJ carried out cell cultures, QRT-PCR, QPCR, conceived the study, participated in its design, and drafted the manuscript. MZ analyzed the data and performed the statistical analysis. ZTZ and HLP critically revised the manuscript. WGJ and ZMG participated in the design of the study. DS conceived the study. BT conceived the study, participated in its design. JAC conceived the study, participated in its design and coordination, and contributed to the final drafting and critical revision of the manuscript. All authors read and approved the final manuscript.</p></sec></body><back><ack><sec><title>Acknowledgements</title><p>This investigation was supported by Maryland Cigarette Restitution Fund and NIDCR 1R01DE015939-01 [JC]; NIH Head and Neck SPORE [WHW, WK, DS, and JC]; the Damon Runyon Cancer Research Foundation CI-#9 [JC].</p></sec></ack><ref-list><ref id="B1"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Forastiere</surname><given-names>A</given-names></name><name><surname>Koch</surname><given-names>W</given-names></name><name><surname>Trotti</surname><given-names>A</given-names></name><name><surname>Sidransky</surname><given-names>D</given-names></name></person-group><article-title>Head and neck cancer</article-title><source>N Engl J Med</source><year>2001</year><volume>345</volume><fpage>1890</fpage><lpage>18900</lpage><pub-id pub-id-type="pmid">11756581</pub-id><pub-id pub-id-type="doi">10.1056/NEJMra001375</pub-id></citation></ref><ref id="B2"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ohishi</surname><given-names>K</given-names></name><name><surname>Inoue</surname><given-names>N</given-names></name><name><surname>Kinoshita</surname><given-names>T</given-names></name></person-group><article-title>PIG-S and PIG-T, essential for GPI anchor attachment to proteins, form a complex with GAA1 and GPI8</article-title><source>Embo J</source><year>2001</year><volume>20</volume><fpage>4088</fpage><lpage>4098</lpage><pub-id pub-id-type="pmid">11483512</pub-id><pub-id pub-id-type="doi">10.1093/emboj/20.15.4088</pub-id></citation></ref><ref id="B3"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hong</surname><given-names>Y</given-names></name><name><surname>Ohishi</surname><given-names>K</given-names></name><name><surname>Kang</surname><given-names>JY</given-names></name><name><surname>Tanaka</surname><given-names>S</given-names></name><name><surname>Inoue</surname><given-names>N</given-names></name><name><surname>Nishimura</surname><given-names>J</given-names></name><name><surname>Maeda</surname><given-names>Y</given-names></name><name><surname>Kinoshita</surname><given-names>T</given-names></name></person-group><article-title>Human PIG-U and yeast Cdc91p are the fifth subunit of GPI transamidase that attaches GPI-anchors to proteins</article-title><source>Mol Biol Cell</source><year>2003</year><volume>14</volume><fpage>1780</fpage><lpage>1789</lpage><pub-id pub-id-type="pmid">12802054</pub-id><pub-id pub-id-type="doi">10.1091/mbc.E02-12-0794</pub-id></citation></ref><ref id="B4"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hamburger</surname><given-names>D</given-names></name><name><surname>Egerton</surname><given-names>M</given-names></name><name><surname>Riezman</surname><given-names>H</given-names></name></person-group><article-title>Yeast Gaa1p is required for attachment of a completed GPI anchor onto proteins</article-title><source>J Cell Biol</source><year>1995</year><volume>129</volume><fpage>629</fpage><lpage>639</lpage><pub-id pub-id-type="pmid">7730400</pub-id><pub-id pub-id-type="doi">10.1083/jcb.129.3.629</pub-id></citation></ref><ref id="B5"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Benghezal</surname><given-names>M</given-names></name><name><surname>Benachour</surname><given-names>A</given-names></name><name><surname>Rusconi</surname><given-names>S</given-names></name><name><surname>Aebi</surname><given-names>M</given-names></name><name><surname>Conzelmann</surname><given-names>A</given-names></name></person-group><article-title>Yeast Gpi8p is essential for GPI anchor attachment onto proteins</article-title><source>Embo J</source><year>1996</year><volume>15</volume><fpage>6575</fpage><lpage>6583</lpage><pub-id pub-id-type="pmid">8978684</pub-id></citation></ref><ref id="B6"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yu</surname><given-names>J</given-names></name><name><surname>Nagarajan</surname><given-names>S</given-names></name><name><surname>Knez</surname><given-names>JJ</given-names></name><name><surname>Udenfriend</surname><given-names>S</given-names></name><name><surname>Chen</surname><given-names>R</given-names></name><name><surname>Medof</surname><given-names>ME</given-names></name></person-group><article-title>The affected gene underlying the class K glycosylphosphatidylinositol (GPI) surface protein defect codes for the GPI transamidase</article-title><source>Proc Natl Acad Sci USA</source><year>1997</year><volume>94</volume><fpage>12580</fpage><lpage>12585</lpage><pub-id pub-id-type="pmid">9356492</pub-id><pub-id pub-id-type="doi">10.1073/pnas.94.23.12580</pub-id></citation></ref><ref id="B7"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hiroi</surname><given-names>Y</given-names></name><name><surname>Komuro</surname><given-names>I</given-names></name><name><surname>Chen</surname><given-names>R</given-names></name><name><surname>Hosoda</surname><given-names>T</given-names></name><name><surname>Mizuno</surname><given-names>T</given-names></name><name><surname>Kudoh</surname><given-names>S</given-names></name><name><surname>Georgescu</surname><given-names>SP</given-names></name><name><surname>Medof</surname><given-names>ME</given-names></name><name><surname>Yazaki</surname><given-names>Y</given-names></name></person-group><article-title>Molecular cloning of human homolog of yeast GAA1 which is required for attachment of glycosylphosphatidylinositols to proteins</article-title><source>FEBS Lett</source><year>1998</year><volume>421</volume><fpage>252</fpage><lpage>258</lpage><pub-id pub-id-type="pmid">9468317</pub-id><pub-id pub-id-type="doi">10.1016/S0014-5793(97)01576-7</pub-id></citation></ref><ref id="B8"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ohishi</surname><given-names>K</given-names></name><name><surname>Inoue</surname><given-names>N</given-names></name><name><surname>Maeda</surname><given-names>Y</given-names></name><name><surname>Takeda</surname><given-names>J</given-names></name><name><surname>Riezman</surname><given-names>H</given-names></name><name><surname>Kinoshita</surname><given-names>T</given-names></name></person-group><article-title>Gaa1p and gpi8p are components of a glycosylphosphatidylinositol (GPI) transamidase that mediates attachment of GPI to proteins</article-title><source>Mol Biol Cell</source><year>2000</year><volume>11</volume><fpage>1523</fpage><lpage>1533</lpage><pub-id pub-id-type="pmid">10793132</pub-id></citation></ref><ref id="B9"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fraering</surname><given-names>P</given-names></name><name><surname>Imhof</surname><given-names>I</given-names></name><name><surname>Meyer</surname><given-names>U</given-names></name><name><surname>Strub</surname><given-names>JM</given-names></name><name><surname>van Dorsselaer</surname><given-names>A</given-names></name><name><surname>Vionnet</surname><given-names>C</given-names></name><name><surname>Conzelmann</surname><given-names>A</given-names></name></person-group><article-title>The GPI transamidase complex of Saccharomyces cerevisiae contains Gaa1p, Gpi8p, and Gpi16p</article-title><source>Mol Biol Cell</source><year>2001</year><volume>12</volume><fpage>3295</fpage><lpage>3306</lpage><pub-id pub-id-type="pmid">11598210</pub-id></citation></ref><ref id="B10"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ohishi</surname><given-names>K</given-names></name><name><surname>Nagamune</surname><given-names>K</given-names></name><name><surname>Maeda</surname><given-names>Y</given-names></name><name><surname>Kinoshita</surname><given-names>T</given-names></name></person-group><article-title>Two subunits of glycosylphosphatidylinositol transamidase, GPI8 and PIG-T, form a functionally important intermolecular disulfide bridge</article-title><source>J Biol Chem</source><year>2003</year><volume>278</volume><fpage>13959</fpage><lpage>13967</lpage><pub-id pub-id-type="pmid">12582175</pub-id><pub-id pub-id-type="doi">10.1074/jbc.M300586200</pub-id></citation></ref><ref id="B11"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nagamune</surname><given-names>K</given-names></name><name><surname>Ohishi</surname><given-names>K</given-names></name><name><surname>Ashida</surname><given-names>H</given-names></name><name><surname>Hong</surname><given-names>Y</given-names></name><name><surname>Hino</surname><given-names>J</given-names></name><name><surname>Kangawa</surname><given-names>K</given-names></name><name><surname>Inoue</surname><given-names>N</given-names></name><name><surname>Maeda</surname><given-names>Y</given-names></name><name><surname>Kinoshita</surname><given-names>T</given-names></name></person-group><article-title>GPI transamidase of Trypanosoma brucei has two previously uncharacterized (trypanosomatid transamidase 1 and 2) and three common subunits</article-title><source>Proc Natl Acad Sci USA</source><year>2003</year><volume>100</volume><fpage>10682</fpage><lpage>10687</lpage><pub-id pub-id-type="pmid">12958211</pub-id><pub-id pub-id-type="doi">10.1073/pnas.1833260100</pub-id></citation></ref><ref id="B12"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sharma</surname><given-names>DK</given-names></name><name><surname>Vidugiriene</surname><given-names>J</given-names></name><name><surname>Bangs</surname><given-names>JD</given-names></name><name><surname>Menon</surname><given-names>AK</given-names></name></person-group><article-title>A cell-free assay for glycosylphosphatidylinositol anchoring in African trypanosomes</article-title><source>J Biol Chem</source><year>1999</year><volume>274</volume><fpage>16479</fpage><lpage>16486</lpage><pub-id pub-id-type="pmid">10347210</pub-id><pub-id pub-id-type="doi">10.1074/jbc.274.23.16479</pub-id></citation></ref><ref id="B13"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Meyer</surname><given-names>U</given-names></name><name><surname>Benghezal</surname><given-names>M</given-names></name><name><surname>Imhof</surname><given-names>I</given-names></name><name><surname>Conzelmann</surname><given-names>A</given-names></name></person-group><article-title>Active site determination of Gpi8p, a caspase-related enzyme required for glycosylphosphatidylinositol anchor addition to proteins</article-title><source>Biochemistry</source><year>2000</year><volume>39</volume><fpage>3461</fpage><lpage>3471</lpage><pub-id pub-id-type="pmid">10727241</pub-id><pub-id pub-id-type="doi">10.1021/bi992186o</pub-id></citation></ref><ref id="B14"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Vidugiriene</surname><given-names>J</given-names></name><name><surname>Vainauskas</surname><given-names>S</given-names></name><name><surname>Johnson</surname><given-names>AE</given-names></name><name><surname>Menon</surname><given-names>AK</given-names></name></person-group><article-title>Endoplasmic reticulum proteins involved in glycosylphosphatidylinositol-anchor attachment: photocrosslinking studies in a cell-free system</article-title><source>Eur J Biochem</source><year>2001</year><volume>268</volume><fpage>2290</fpage><lpage>2300</lpage><pub-id pub-id-type="pmid">11298746</pub-id><pub-id pub-id-type="doi">10.1046/j.1432-1327.2001.02106.x</pub-id></citation></ref><ref id="B15"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Vainauskas</surname><given-names>S</given-names></name><name><surname>Menon</surname><given-names>AK</given-names></name></person-group><article-title>A conserved proline in the last transmembrane segment of Gaa1 is required for glycosylphosphatidylinositol (GPI) recognition by GPI transamidase</article-title><source>J Biol Chem</source><year>2004</year><volume>279</volume><fpage>6540</fpage><lpage>6545</lpage><pub-id pub-id-type="pmid">14660601</pub-id><pub-id pub-id-type="doi">10.1074/jbc.M312191200</pub-id></citation></ref><ref id="B16"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Guo</surname><given-names>Z</given-names></name><name><surname>Linn</surname><given-names>JF</given-names></name><name><surname>Wu</surname><given-names>G</given-names></name><name><surname>Anzick</surname><given-names>SL</given-names></name><name><surname>Eisenberger</surname><given-names>CF</given-names></name><name><surname>Halachmi</surname><given-names>S</given-names></name><name><surname>Cohen</surname><given-names>Y</given-names></name><name><surname>Fomenkov</surname><given-names>A</given-names></name><name><surname>Hoque</surname><given-names>MO</given-names></name><name><surname>Okami</surname><given-names>K</given-names></name><name><surname>Steiner</surname><given-names>G</given-names></name><name><surname>Engles</surname><given-names>JM</given-names></name><name><surname>Osada</surname><given-names>M</given-names></name><name><surname>Moon</surname><given-names>C</given-names></name><name><surname>Ratovitski</surname><given-names>E</given-names></name><name><surname>Trent</surname><given-names>JM</given-names></name><name><surname>Meltzer</surname><given-names>PS</given-names></name><name><surname>Westra</surname><given-names>WH</given-names></name><name><surname>Kiemeney</surname><given-names>LA</given-names></name><name><surname>Schoenberg</surname><given-names>MP</given-names></name><name><surname>Sidransky</surname><given-names>D</given-names></name><name><surname>Trink</surname><given-names>B</given-names></name></person-group><article-title>CDC91L1 (PIG-U) is a newly discovered oncogene in human bladder cancer</article-title><source>Nat Med</source><year>2004</year><volume>10</volume><fpage>374</fpage><lpage>381</lpage><pub-id pub-id-type="pmid">15034568</pub-id><pub-id pub-id-type="doi">10.1038/nm1010</pub-id></citation></ref><ref id="B17"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>G</given-names></name><name><surname>Guo</surname><given-names>Z</given-names></name><name><surname>Chatterjee</surname><given-names>A</given-names></name><name><surname>Huang</surname><given-names>X</given-names></name><name><surname>Rubin</surname><given-names>E</given-names></name><name><surname>Wu</surname><given-names>F</given-names></name><name><surname>Mambo</surname><given-names>E</given-names></name><name><surname>Chang</surname><given-names>X</given-names></name><name><surname>Osada</surname><given-names>M</given-names></name><name><surname>Sook Kim</surname><given-names>M</given-names></name><name><surname>Moon</surname><given-names>C</given-names></name><name><surname>Califano</surname><given-names>JA</given-names></name><name><surname>Ratovitski</surname><given-names>EA</given-names></name><name><surname>Gollin</surname><given-names>SM</given-names></name><name><surname>Sukumar</surname><given-names>S</given-names></name><name><surname>Sidransky</surname><given-names>D</given-names></name><name><surname>Trink</surname><given-names>B</given-names></name></person-group><article-title>Overexpression of glycosylphosphatidylinositol (GPI) transamidase subunits phosphatidylinositol glycan class T and/or GPI anchor attachment 1 induces tumorigenesis and contributes to invasion in human breast cancer</article-title><source>Cancer Res</source><year>2006</year><volume>66</volume><fpage>9829</fpage><lpage>36</lpage><pub-id pub-id-type="pmid">17047043</pub-id><pub-id pub-id-type="doi">10.1158/0008-5472.CAN-06-0506</pub-id></citation></ref><ref id="B18"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Albertson</surname><given-names>DG</given-names></name></person-group><article-title>Profiling breast cancer by array CGH</article-title><source>Breast Cancer Res Treat</source><year>2003</year><volume>78</volume><fpage>289</fpage><lpage>98</lpage><pub-id pub-id-type="pmid">12755488</pub-id><pub-id pub-id-type="doi">10.1023/A:1023025506386</pub-id></citation></ref><ref id="B19"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ethier</surname><given-names>SP</given-names></name></person-group><article-title>Identifying and validating causal genetic alterations in human breast cancer</article-title><source>Breast Cancer Res Treat</source><year>2003</year><volume>78</volume><fpage>285</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">12755487</pub-id><pub-id pub-id-type="doi">10.1023/A:1023078722316</pub-id></citation></ref><ref id="B20"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kallioniemi</surname><given-names>A</given-names></name><name><surname>Kallioniemi</surname><given-names>OP</given-names></name><name><surname>Sudar</surname><given-names>D</given-names></name><name><surname>Rutovitz</surname><given-names>D</given-names></name><name><surname>Gray</surname><given-names>JW</given-names></name><name><surname>Waldman</surname><given-names>F</given-names></name><name><surname>Pinkel</surname><given-names>D</given-names></name></person-group><article-title>Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors</article-title><source>Science</source><year>1992</year><volume>258</volume><fpage>818</fpage><lpage>21</lpage><pub-id pub-id-type="pmid">1359641</pub-id><pub-id pub-id-type="doi">10.1126/science.1359641</pub-id></citation></ref><ref id="B21"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bergamo</surname><given-names>NA</given-names></name><name><surname>da Silva Veiga</surname><given-names>LC</given-names></name><name><surname>dos Reis</surname><given-names>PP</given-names></name><name><surname>Nishimoto</surname><given-names>IN</given-names></name><name><surname>Magrin</surname><given-names>J</given-names></name><name><surname>Kowalski</surname><given-names>LP</given-names></name><name><surname>Squire</surname><given-names>JA</given-names></name><name><surname>Rogatto</surname><given-names>SR</given-names></name></person-group><article-title>Classic and molecular cytogenetic analyses reveal chromosomal gains and losses correlated with survival in head and neck cancer patients</article-title><source>Clin Cancer Res</source><year>2005</year><volume>11</volume><fpage>621</fpage><lpage>631</lpage><pub-id pub-id-type="pmid">15701849</pub-id></citation></ref><ref id="B22"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>Q</given-names></name><name><surname>Yu</surname><given-names>GP</given-names></name><name><surname>McCormick</surname><given-names>SA</given-names></name><name><surname>Mo</surname><given-names>J</given-names></name><name><surname>Datta</surname><given-names>B</given-names></name><name><surname>Mahimkar</surname><given-names>M</given-names></name><name><surname>Lazarus</surname><given-names>P</given-names></name><name><surname>Schaffer</surname><given-names>AA</given-names></name><name><surname>Desper</surname><given-names>R</given-names></name><name><surname>Schantz</surname><given-names>SP</given-names></name></person-group><article-title>Genetic differences detected by comparative genomic hybridization in head and neck squamous cell carcinomas from different tumor sites: construction of oncogenetic trees for tumor progression</article-title><source>Genes Chromosomes Cancer</source><year>2002</year><volume>34</volume><fpage>224</fpage><lpage>233</lpage><pub-id pub-id-type="pmid">11979556</pub-id><pub-id pub-id-type="doi">10.1002/gcc.10062</pub-id></citation></ref><ref id="B23"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Liebig</surname><given-names>B</given-names></name><name><surname>Brabletz</surname><given-names>T</given-names></name><name><surname>Staege</surname><given-names>MS</given-names></name><name><surname>Wulfanger</surname><given-names>J</given-names></name><name><surname>Riemann</surname><given-names>D</given-names></name><name><surname>Burdach</surname><given-names>S</given-names></name><name><surname>Ballhausen</surname><given-names>WG</given-names></name></person-group><article-title>Forced expression of deltaN-TCF-1B in colon cancer derived cell lines is accompanied by the induction of CEACAM5/6 and mesothelin</article-title><source>Cancer Lett</source><year>2005</year><volume>223</volume><fpage>159</fpage><lpage>167</lpage><pub-id pub-id-type="pmid">15890249</pub-id><pub-id pub-id-type="doi">10.1016/j.canlet.2004.10.013</pub-id></citation></ref><ref id="B24"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jiang</surname><given-names>WW</given-names></name><name><surname>Masayesva</surname><given-names>B</given-names></name><name><surname>Zahurak</surname><given-names>M</given-names></name><name><surname>Carvalho</surname><given-names>AL</given-names></name><name><surname>Rosenbaum</surname><given-names>E</given-names></name><name><surname>Mambo</surname><given-names>E</given-names></name><name><surname>Zhou</surname><given-names>S</given-names></name><name><surname>Minhas</surname><given-names>K</given-names></name><name><surname>Benoit</surname><given-names>N</given-names></name><name><surname>Westra</surname><given-names>WH</given-names></name><name><surname>Alberg</surname><given-names>A</given-names></name><name><surname>Sidransky</surname><given-names>D</given-names></name><name><surname>Califano</surname><given-names>AJ</given-names></name></person-group><article-title>Increased mitochondrial DNA content in saliva associated with head and neck cancer</article-title><source>Clin Cancer Res</source><year>2005</year><volume>11</volume><fpage>2486</fpage><lpage>2491</lpage><pub-id pub-id-type="pmid">15814624</pub-id><pub-id pub-id-type="doi">10.1158/1078-0432.CCR-04-2147</pub-id></citation></ref></ref-list></back></article> 